ANVISA registration

Parvovírus B19 IgM

Registration 10338930161. PARVOVÍRUS B 19

Registration details

Registration number10338930161
Application number25351634718201426
Technical namePARVOVÍRUS B 19
Risk classIII
Published on19/01/2015
ValidityValid until 19/01/2035

Registration holder

Legal nameEUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA
CNPJ93.741.726/0001-66

Manufacturer

  • EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG ALEMANHA

Other registrations held by EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAview all

Anti-cardiolipina IgM

10338930040

ANTI-TRANSGLUTAMINASE TECIDUAL ELISA IgA EA 1910-9601 A

10338930041

ANTI-GLIADINA GAF-3X ELISA IGG EV3011-9601 G

10338930042

ANTI-SSB ELISA IgG EA 1597-9601 G

10338930043

ANTI-CARDIOLIPINA ELISA IgA EA 1621-9601 A

10338930044

ANTI-GLIADINA GAF-3X ELISA IgA EV3011-9601 A

10338930045

Source: ANVISA

Source: ANVISA open data, medical device file, updated daily. The public database provides registration validity, rather than registration status: this registration may have been cancelled before its expiry date without this being shown here. Before making purchasing, import or marketing decisions, check the ANVISA search portal.

Next step

Medical device registration with ANVISA

HSC manages the process from risk classification to liaising with the regulator, in Brazil and more than 40 other countries.

Speak to a specialist